Literature DB >> 34628795

Expression of interferon regulatory factor 4 and inflammation in secondary injury of intracerebral haemorrhage.

Bingqian Wang1, Xiaopeng Li2, Tianyu Dong3, Feng Gao1, Zhenzhong Li1, Zenglu Ma1.   

Abstract

The aim of this study was to investigate the expression of interferon regulatory factor 4 (IRF4) and the inflammatory response in secondary injury of intracerebral haemorrhage (ICH). Twelve SD rats were randomly divided into a sham group and an ICH group, with 6 rats in each group. A rat model of ICH was established by injecting collagenase type IV into the right striatum of rats. The expression of IRF4 was measured by western blot and immunohistochemistry 48 h after ICH. In addition, 15 mm of hemin-induced PC12 cell injury was used to simulate an in vitro ICH model. IRF4 expression was detected by immunofluorescence (IF). Moreover, the inflammatory cytokines (IL-1b and IL-6) were measured by ELISA. The behavioural score of ICH rats was the lowest at 48 h after operation. The expression of IRF4 was significantly higher in the striatal tissue of ICH rats compared with the sham group (p < 0.05). Meanwhile, IF results showed that hemin induced the upregulation of IRF4 expression in rat pheochromocytoma cells PC12. In addition, IL-1b and IL-6 levels were significantly increased in the serum of ICH rats and in the supernatant of hemin-induced PC12 cells (p < 0.01). The inflammation in ICH is related to the increase of IRF4. It provides a theoretical basis for the clinical treatment of ICH.

Entities:  

Keywords:  inflammation; interferon regulatory factor 4 (IRF4); secondary injury; treatment.; intracerebral haemorrhage (ICH)

Mesh:

Substances:

Year:  2021        PMID: 34628795     DOI: 10.5114/fn.2021.109200

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  1 in total

1.  Biomarker Associations in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage.

Authors:  Dora Spantler; Tihamer Molnar; Diana Simon; Timea Berki; Andras Buki; Attila Schwarcz; Peter Csecsei
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.